Statistics
Publications
7
Citations
228
H-Index
7
Active since
2018
Lanhong Su is an author at University of Science and Technology of China specializing in oncology, medicine, and nanomedicine.
Publications per year
2018–2022
7
7
Carboxylesterase-Cleavable Biotinylated Nanoparticle for Tumor-Dual Targeted Imaging
Peiyao Chen, Wen Kuang, Zhen Zheng et al. · Theranostics · 2019 · 56 citations · Full text
Legumain-Specific Near-Infrared Fluorescence “Turn On” for Tumor-Targeted Imaging
Yue Zhao, Zijuan Hai, Hongyong Wang et al. · Analytical Chemistry · 2018 · 49 citations
DIS3L2 Promotes Progression of Hepatocellular Carcinoma via hnRNP U-Mediated Alternative Splicing
Songge Xing, Zhaoyong Li, Wenhao Ma et al. · Cancer Research · 2019 · 49 citations · Full text
Medicine, Cancer Biology, Oncology +17
Systematic co-delivery of dual agonists to enhance cancer immunotherapy
Xiangxia Li, Guiyuan Chen, Yangyi Wang et al. · Nano Research · 2022 · 23 citations
Pharmacy, Oncology, Pharmacology +15
Zhenzhen Jiang, Xi Geng, Lanhong Su et al. · Materials Today Chemistry · 2022 · 23 citations · Full text
1–5 of 7